Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Blood bank software premarket submission deadline extended by one year -- FDA.

This article was originally published in The Gray Sheet

  • News

Executive Summary

BLOOD BANK SOFTWARE PREMARKET SUBMISSION DEADLINE EXTENDED by one year to March 31, 1996, FDA says in a Feb. 10 letter to manufacturers of computer software used by blood banks. FDA says it is extending the deadline from March 31, 1995 "after careful evaluation of the concerns expressed by software manufacturers, the impact of the regulatory initiative on blood establishments, and the public health significance of assuring the safety and quality of this software."

Table

View full table

Tags:
Latest Headlines

Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch

CDRH’s AR/VR Home Space Will Serve As An ‘Idea Lab’ For Device Stakeholders

EU Regulatory Roundup, April 2024: EU On Cusp Of Regulatory Shifts Amidst Political Change

Abbott Receives FDA Approval For Esprit BTK Drug-Eluting Resorbable Scaffold

See All
UsernamePublicRestriction

Register

MT003505

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By